– Advancing Phase 2 clinical trials of verekitug in patients with severe asthma and CRSwNP – – Commenced startup for a Phase 2 clinical trial in COPD; on track for first patient to be dosed in H2...
WALTHAM, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus...
WALTHAM, Mass., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.89 | -3.32089552239 | 26.8 | 29.3 | 25.05 | 168495 | 26.44682234 | CS |
4 | 2.71 | 11.6810344828 | 23.2 | 29.35 | 21.2 | 282398 | 25.54549812 | CS |
12 | 4.41 | 20.511627907 | 21.5 | 29.35 | 20.74 | 364074 | 24.54129421 | CS |
26 | 4.41 | 20.511627907 | 21.5 | 29.35 | 20.74 | 364074 | 24.54129421 | CS |
52 | 4.41 | 20.511627907 | 21.5 | 29.35 | 20.74 | 364074 | 24.54129421 | CS |
156 | 4.41 | 20.511627907 | 21.5 | 29.35 | 20.74 | 364074 | 24.54129421 | CS |
260 | 4.41 | 20.511627907 | 21.5 | 29.35 | 20.74 | 364074 | 24.54129421 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約